These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19567713)

  • 1. Issues in long-term opioid therapy: unmet needs, risks, and solutions.
    Passik SD
    Mayo Clin Proc; 2009 Jul; 84(7):593-601. PubMed ID: 19567713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical strategies for the primary health care professional to minimize prescription opioid abuse.
    Gudin JA
    Postgrad Med; 2012 May; 124(3):131-8. PubMed ID: 22691907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid formulations designed to resist/deter abuse.
    Raffa RB; Pergolizzi JV
    Drugs; 2010 Sep; 70(13):1657-75. PubMed ID: 20731474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
    Bannwarth B
    Drugs; 2012 Sep; 72(13):1713-23. PubMed ID: 22931520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-deterrent opioids: an update on current approaches and considerations.
    Pergolizzi JV; Raffa RB; Taylor R; Vacalis S
    Curr Med Res Opin; 2018 Apr; 34(4):711-723. PubMed ID: 29262730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamper-resistant opioid formulations in the treatment of acute pain.
    Passik SD
    Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
    Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
    Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
    Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N
    J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
    Webster L
    Pain Med; 2009 Jul; 10 Suppl 2():S124-33. PubMed ID: 19691683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.
    Brushwood DB; Rich BA; Coleman JJ; Bolen J; Wong W
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):333-48. PubMed ID: 21133741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Opioid Abuse and Treatment of Opioid Addiction: Current Status and Future Possibilities.
    Park K; Otte A
    Annu Rev Biomed Eng; 2019 Jun; 21():61-84. PubMed ID: 30786212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Perioperative Surgical Home in Optimizing the Perioperative Use of Opioids.
    Vetter TR; Kain ZN
    Anesth Analg; 2017 Nov; 125(5):1653-1657. PubMed ID: 28742770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
    Gasior M; Bond M; Malamut R
    Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.